Company: BIVIW
Filing Date: 2025-05-15
Form Type: DRS
Source: 0001520138-25-000149
Chunk: 45

Company: BIOVIE INC.
Filing Date: 2025-05-15
Form: DRS
Chunk 45
---
 aggregate
purchase price paid by each Excluded Purchaser). We have also agreed to pay a non-accountable expense allowance to the Representative
equal to 1% of the gross proceeds received in this offering from purchasers other than the Excluded Purchasers.

The underwriters propose initially to offer the
Units and/or Pre-funded Units to the public at the public offering price set forth on the cover page of this prospectus and to dealers
at that price less a concession not in excess of $ per Unit and $
per Pre-funded Unit. If all of the Units and/or Pre-funded Units offered by us are not sold at the public offering price, the underwriters
may change the public offering price and other selling terms by means of a supplement to this prospectus.

The following table shows the public offering
price, underwriting discounts and proceeds, before expenses, to us. The information assumes either no exercise or full exercise by the
underwriters of their over-allotment option.

<div align='center'>30</div>

|                                               |     | Per Unit |     | Per        
 Pre-funded 
 Unit       |     | Total Assuming No Exercise of 
 Over- Allotment               
 Option                        |     | Total Assuming Full Exercise of 
 Over- Allotment                 
 Option                          |
|:----------------------------------------------|:----|:---------|:----|:-----------|:----|:------------------------------|:----|:--------------------------------|
| Public offering price                         |     | $        |     | $          |     | $                             |     | $                               |
| Underwriting discounts and commissions (7.0%) |     | $        |     | $          |     | $                             |     | $                               |
| Proceeds, before expense, to us               |     | $        |     | $          |     | $                             |     | $                               |

In addition, we will also pay the Representative
(a) all filing fees and communication expenses relating to the securities to be sold in this offering with the SEC; (b) all filing fees
and expenses associated with the review of this offering by FINRA; (c) all fees and expenses relating to the listing of the securities
on the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE or the NYSE American and on such other
stock exchanges as the Company and the underwriters together determine, including any fees charged by The Depository Trust Company (DTC)
for new securities; (d) all fees